基因预测的氨基酸血水平和与代谢功能障碍相关的脂肪肝疾病风险:孟德尔的随机化研究
Jian Zhao1,2,3, Jing Zeng4, Cairong Zhu5
1The Ministry of Education and Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Yangpu District, Shanghai, 200092, China. jzhao.epi@gmail.com.
BMC medicine
|November 29, 2023
概括
较高的氨酸和较低的谷氨胺水平可能会因果性地增加患有代谢功能障碍相关脂肪肝疾病 (MAFLD) 的风险. 这项研究使用了门德尔的随机化来研究氨基酸代谢.
科学领域:
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 代谢学研究表明,氨基酸代谢与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 之间存在联系.
- 氨基酸代谢在MAFLD发展中的特殊病因作用需要进一步研究.
研究的目的:
- 使用孟德尔随机化方法评估循环氨基酸水平和MAFLD风险之间的因果关系.
主要方法:
- 使用全基因组关联研究 (GWAS) 总结数据进行了两样本的门德尔随机化分析.
- 发现和复制分析使用了大型MAFLD GWAS数据集,敏感性分析包括加权中位数和MR-Egger回归.
- 保守的分析将遗传仪器限制在那些直接参与氨基酸代谢途径的人身上.
主要成果:
- 基因预测较高的氨酸水平 (OR = 1.43) 与MAFLD风险增加有关.
- 基因预测较低的谷氨胺水平 (OR = 0.83) 与MAFLD风险增加有关.
- 灵敏度和补充分析支持了这些发现,使用肝脏质子密度脂肪分数作为代理结果.
结论:
- 门德尔随机化确定了与MAFLD发展相关的新因果代谢物.
- 氨酸和谷氨酸可能是MAFLD预防或治疗策略的潜在目标.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.0K
相关概念视频
Inborn Errors of Metabolism
165
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
165
Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
